Clinical Trial Update: A Study of Flovent in Patients With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for Flovent in eosinophilic esophagitis study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Flovent (fluticasone propionate)

Snippet

Sponsor: Marc Rothenberg, MD | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2014-02-03